Unknown PHASE2 INTERVENTIONAL 2-arm NCT05143723

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

Sponsor: Kuban State Medical University

Interventions Gonadotropin-releasing hormone agonist

Updated 5 times since 2022 Last updated: Nov 20, 2021 Started: Jan 20, 2020 Primary completion: Apr 15, 2021 Completion: Jun 10, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Infertility, this trial is ongoing. The trial is conducted by Kuban State Medical University and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Dec 2023 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Jan 2022 — Dec 2023 [monthly]

Active Not Recruiting PHASE2

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kuban State Medical University

Data source: Kuban State Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Krasnodar, Russia